Hepatitis C New Zealand treatment numbers from 2009 – 2011
This information is a reply to a official information act request for these figures from NZ ministry of Health May 2012
Interesting to note the significant decline in numbers treated for Hepatitis C over this period
2009 = 721
2010 = 578
2011 = 478
New Zealand Hepatitis C treatment figures, which include the number of patients in each district health board (DHB) who have completed treatment for hepatitis C with Pegylated Interferon and Ribavirin during 2011 and the preceding years as follows..
| 2009 | 2010 | 2011 | |||
| Auckland | 131 | 43 | 36 | ||
| Bay of Plenty | 36 | 32 | 27 | ||
| Canterbury | 90 | 81 | 45 | ||
| Capital and Coast | 41 | 40 | 21 | ||
| Counties Manukau | 56 | 34 | 37 | ||
| Hawkes Bay | 15 | 8 | 11 | ||
| Hutt Valley | 14 | 19 | 20 | ||
| Lakes | 19 | 19 | 19 | ||
| Mid Central | 20 | 28 | 19 | ||
| Nelson Marlborough | 27 | 24 | 28 | ||
| Northland | 28 | 25 | 17 | ||
| Otago | 32 | 44 | 48 | ||
| South Canterbury | 9 | 6 | 6 | ||
| Southland | 12 | 17 | 6 | ||
| Tairawhiti | 1 | 2 | 7 | ||
| Taranaki | 16 | 25 | 22 | ||
| Waikato | 24 | 31 | 13 | ||
| Wairarapa | 9 | 2 | 7 | ||
| Waitemata | 75 | 58 | 43 | ||
| West Coast | 10 | 13 | 10 | ||
| Whanganui | 25 | 16 | 23 | ||
| Unknown | 31 | 11 | 13 | ||
| 721 | 578 | 478 | |||
I thought decline in numbers treated might have something to do with drug trials but apparently these figures include those on drug trials that use Pegylated Interferon and Ribavirin
“In answer to your question, PHARMAC determine the funding of a product in the community and the restrictions (if any) that apply to it. In the case of pegylated interferon with or without ribavirin we fund these products for patients who meet the Special Authority criteria. There is nothing in our Special Authority criteria that would prohibit a patient undergoing a clinical trial receiving a funded therapy. We do not actively fund therapy in pharmaceutical trials, therefore anyone who is receiving funded therapy met our funding criteria as well as the entry criteria for the trial. ”
Greg Williams | Senior Therapeutic Group Manager Pharmac
And in case your wondering where unknown is , that likely means the patient ( a NZ citizen ) was treated in another country where they are resident.
best of health
www.hcv.org.nz
“A community of people with hepatitis C trying to help other people who are affected by hepatitis C”